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ABSTRACT Commensal bifidobacteria colonize the human gastrointestinal tract and
catabolize glycans that are impervious to host digestion. Accordingly, Bifidobacterium
longum typically secretes acetate and lactate as fermentative end products. This
study tested the hypothesis that B. longum utilizes cranberry-derived xyloglucans in
a strain-dependent manner. Interestingly, the B. longum strain that efficiently utilizes
cranberry xyloglucans secretes 2.0 to 2.5 mol of acetate-lactate. The 1.5 acetate:lac-
tate ratio theoretical yield obtained in hexose fermentations shifts during xyloglucan
metabolism. Accordingly, this metabolic shift is characterized by increased acetate
and formate production at the expense of lactate. -L-Arabinofuranosidase, an arabi-
nan endo-1,5--L-arabinosidase, and a -xylosidase with a carbohydrate substrate-
binding protein and carbohydrate ABC transporter membrane proteins are upregu-
lated (2-fold change), which suggests carbon flux through this catabolic pathway.
Finally, syntrophic interactions occurred with strains that utilize carbohydrate prod-
ucts derived from initial degradation from heterologous bacteria.
IMPORTANCE This was a study of bacterial metabolism of complex cranberry carbo-
hydrates termed xyloglucans that are likely not digested prior to reaching the colon.
This is significant, as bifidobacteria interact with this dietary compound to poten-
tially impact human host health through energy and metabolite production by utiliz-
ing these substrates. Specific bacterial strains utilize cranberry xyloglucans as a nutri-
tive source, indicating unknown mechanisms that are not universal in bifidobacteria.
In addition, xyloglucan metabolism proceeds by using an alternative pathway that
could lead to further research to investigate mechanisms underlying this interaction.
Finally, we observed cross-feeding between bacteria in which one strain degrades
the cranberry xyloglucan to make it available to a second strain. Similar nutritive
strategies are known to occur within the gut. In aggregate, this study may lead to
novel foods or supplements used to impact human health through rational manipu-
lation of the human microbiome.
KEYWORDS bifidobacteria, food microbiology, prebiotics
Microbial commensals colonize the mammalian gut and interact with their hostthrough various interwoven metabolic networks. A well-characterized operation
performed by microbiota is energy liberation from dietary polysaccharides. These
complex carbohydrates are impervious to host digestion and are thus available for
microbial populations to utilize. In turn, gut microorganisms produce metabolites
sequestered by the host, including short-chain fatty acids (SCFAs) (1–4). Briefly, gut
microorganisms compete for dietary molecules with metabolites secreted by one
member often utilized by a secondary microbial population (5). This syntrophic me-
tabolism is extended toward interactions with their host. For instance, microbial SCFAs
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(i.e., acetate, propionate, butyrate, and valerate) are substrates for specific host tissues.
This includes butyrate, which provides a primary energy source for enterocytes (1, 2, 6).
Bifidobacterium longum is often dominant in the infant gut and colonizes adults at
lower concentrations (7). Whereas B. longum subsp. infantis colonizes the infant gut, B.
longum subsp. longum tends to populate adult microbiomes. As with all bifidobacteria,
B. longum catabolizes carbohydrates via the fructose-6-phosphate phosphoketolase
pathway, which is characteristic of the genus and thus termed the bifid shunt. This
ATP-generating pathway results in acetate and lactate secretion to recycle cofactors
required in substrate level phosphorylation (8, 9). The theoretical yield is an acetate:
lactate ratio of 3:2 mol produced for every 2 mol of hexose that enters the bifid shunt.
Bifidobacteria encode an assortment of glycosyl hydrolases (GHs) in order to utilize
dietary glycans as fermentative substrates (10–12). Oligosaccharide utilization pheno-
types are often consistent with the ecological niche that the bifidobacterial strain
occupies (e.g., the adult versus the infant gut) (13). The B. longum subsp. longum
genome, for example, encodes a large number of GHs dedicated to arabinose and
xylose utilization (14). In contrast, the chromosome of the phylogenetic near neighbor
and infant-colonizing bacterium B. longum subsp. infantis contains genes that enable
human milk oligosaccharide utilization within the nursing infant gut (15–18). In general,
B. longum subsp. infantis varies in its ability to utilize plant-derived carbohydrates (13).
Xyloglucans are cross-linking oligosaccharides found in type 1 plant cell walls (19)
that exhibit a (1¡4)-glucan primary backbone with (1¡6)-linked xylosyl residues as
substituents. Depending on the plant species and tissue of origin, xyloglucan branches
may be extended by galactose, fucose, or arabinose residues (20, 21). The predominant
cranberry xyloglucan structure was previously characterized as SSGG [S, -D-glucose
with -L-Ara-(1, 2)--D-Xyl at the O-6 position; G, (1¡4)-glucan main chain] (22).
Oligosaccharides isolated from the cranberry (Vaccinium macrocarpon) cell wall
prevent the adhesion of uropathogenic Escherichia coli and may limit biofilm produc-
tion (23, 24). With regard to xyloglucan metabolism, certain gut microorganisms
produce enzymes that degrade tamarind seed xyloglucans in their extracellular envi-
ronment (25). However, the structure-function relationship between xyloglucans and
specific populations of commensal bacteria remains unresolved. Thus, we evaluated B.
longum strains for the ability to utilize cranberry-derived xyloglucans as a sole carbon
source. To further understand in vitro metabolism, organic acids produced during
fermentation were profiled. In addition, Lactobacillus strains that are recognized as
probiotics (26) and have potential for use as synbiotics were subjected to growth on
xyloglucans as their sole carbohydrate source.
RESULTS
The cranberry cell wall contains xyloglucans. Oligosaccharides were purified from
a cranberry derivative through reverse-phase C18 and size exclusion chromatography
(see Fig. S1 in the supplemental material). The chemical properties of the purified
oligosaccharides were subsequently assessed by matrix-assisted laser desorption ion-
ization (MALDI-TOF) mass spectrometry (MS) (Fig. 1) and 1H nuclear magnetic reso-
nance (NMR) spectroscopy (Fig. S2). Consistent with previous studies (22, 24), the
purified oligosaccharides were identified as xyloglucans with degrees of polymerization
(DPs) ranging from 6 to 9. MALDI-TOF MS analysis identified sodium adduct ions at 923,
953, 1,055, 1,085, 1,217, 1,247, and 1,379, which were interpreted as xyloglucan
compositions of hexose3-pentose3 (H3P3), H4P2, H3P4, H4P3, H4P4, H5P3, and H5P4,
respectively. Putative cranberry xyloglucan oligosaccharide structures were provision-
ally assigned as reported in Table S1.
B. longum xyloglucan utilization is strain dependent. Among the bifidobacterial
strains tested (Table 1), B. longum subsp. longum UCD401 exhibits the most growth on
the purified xyloglucans, achieving a final optical density at 600 nm (OD600) of 0.15 
0.02 (Fig. 2). The growth rate of B. longum subsp. longum UCD401 while utilizing
xyloglucans does not significantly differ from that during glucose utilization (P  0.05)
(Table 2). This indicates that B. longum subsp. longum UCD401 does not have a
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metabolic preference for glucose relative to xyloglucans. As expected, while fermenting
xyloglucans, B. longum subsp. longum UCD401 achieves a modest biomass relative to
that achieved on glucose (P  0.05) and no growth was observed on the negative
control. This indicates that UCD401 does not utilize these carbohydrates with similar
efficiency. Bifidobacteria that utilize both plant and milk oligosaccharides have exhib-
ited similar growth profiles (27, 28). Despite similar growth rates on glucose and
xyloglucans, B. longum subsp. longum UCD401 ferments xyloglucans more slowly than
glucose to achieve maximal growth (tc) (P  0.05) (Table 2). In contrast to UCD401, B.
longum subsp. infantis ATCC 15697 and JCM1260 did not metabolize cranberry xylog-
lucans.
Lactobacillus strains were evaluated to test if other fermentative bacteria could
harness cranberry xyloglucan carbon. Lactobacillus plantarum ATCC BAA-793 and Lac-
tobacillus johnsonii ATCC 33200 were subjected to growth on xyloglucans as a sole
carbohydrate source as depicted in Fig. 2 with growth kinetics displayed in Table 2. L.
johnsonii ATCC 33200 did not utilize cranberry-derived oligosaccharides. In contrast, L.
plantarum ATCC BAA-793 achieved a final OD600 of 0.29  0.03, which is higher than
FIG 1 Purified cranberry xyloglucan putative structures. Shown is the positive reflectron mode MALDI-TOF MS spectrum of cranberry xyloglucan obtained from
a HiPrep Sephacryl S-100 HR size exclusion column. The voltage was set at 80 kV, and 500 profiles were collected. Major peaks at m/z 923, 953, 1,055, 1,085,
1,217, 1,247, and 1,379 represent sodium adducts ([M  Na]) of xyloglucan with DPs ranging from 6 to 9 and sugar compositions as follows: [H3P3 Na],
m/z 923; [H4P2 Na], m/z 953; [H3P4 Na], m/z 1,055; [H4P3 Na], m/z 1,085; [H4P4 Na], m/z 1,217; [H5P3 Na], m/z 1,247; [H5P4 Na], m/z 1,379.
TABLE 1 Strains used in this study
Straina Species or subspecies Origin
ATCC 15697 B. longum subsp. infantis Human infant feces
JCM 1260 B. longum subsp. infantis Human infant feces
JCM 1272 B. longum subsp. infantis Human infant feces
JCM 7007 B. longum subsp. infantis Human infant feces
JCM 11347 B. longum subsp. longum Human feces
ATCC 15708 B. longum subsp. longum Human feces
UCD401 B. longum subsp. longum Human feces
ATCC BAA-793 L. plantarum Human saliva
ATCC 33200 L. johnsonii Human blood
aUCD, University of California Davis Culture Collection; ATCC, American Type Culture Collection; JCM,
Japanese Collection of Microorganisms.
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that of all of the B. longum strains tested (P 0.05) (Fig. 2). This Lactobacillus strain does
prefer glucose, as it has a significantly lower growth rate while consuming xyloglucans
(P  0.05, Table 2). Its maximal growth (tc) did not vary between xyloglucan and
glucose utilization (P  0.05), despite the lower growth rate during xyloglucan utiliza-
tion. Interestingly, L. plantarum has a lower growth rate than B. longum subsp. longum
UCD401 while fermenting purified xyloglucans despite achieving a higher biomass (P
0.05). The time required to achieve maximum growth (tc) while utilizing xyloglucan is
significantly shorter for L. plantarum than for B. longum subsp. longum UCD401 (P 
0.05). This suggests that L. plantarum does not prefer these complex carbohydrates,
despite having a higher utilization efficiency than the B. longum strain.
B. longum consumes xyloglucans from the growth medium. The extent to which
UCD401 utilizes xyloglucans was determined by profiling spent fermentation medium
from growth conducted in microcentrifuge tubes. Interestingly, degraded glycans were
not detected in spent medium compared with the control (i.e., preinoculated medium)
(Fig. S3 and S4). The extracted ion counts for each xyloglucan were quantitated as
percentages of the baseline control (t  0) (Fig. S5 and S6). Of interest, detectable
xyloglucans with DPs of 6 to 9 exhibited 120% of the extracted ion counts of the
baseline (t  0). Thus, there was an extensive accumulation of xyloglucans with all DPs
following fermentation by B. longum subsp. longum UCD401. Significantly, xyloglucans
with DPs of 7 did not accumulate to the same extent. This is indicative of an ability
to utilize the short-chain oligosaccharides. Accordingly, we did not detect monosac-
charide accumulation in the spent fermentation medium. A similar observation has
been reported previously with bifidobacterial metabolism of human milk oligosaccha-
rides (29, 30). As previously postulated, B. longum is able to transport only lower-
FIG 2 Bacterial growth while utilizing cranberry xyloglucans. Growth curves of B. longum subsp. longum
UCD401, L. plantarum ATCC BAA-793, L. johnsonii ATCC 33200, and B. longum subsp. infantis ATCC 15697
and JCM 1260 grown on mMRS medium containing 2% (wt/vol) xyloglucans. The curves are drawn from
an average of three independent experiments.
TABLE 2 Analysis of bacterial growth kinetics calculated with Wolfram Mathematica 10.3
Strain
2% xyloglucans 2% glucose
k (h1) ODasym tc (h) k (h1) ODasym tc (h)
B. infantis JCM 1260 NDa ND ND ND ND ND
B. infantis ATCC 15697 ND ND ND ND ND ND
B. longum UCD401 0.555 0.055 0.15 0.02b 19.7 2.5d 0.614 0.048 1.25 0.09 13.7 0.6
L. plantarum ATCC BAA-793 0.386 0.049f 0.29 0.03c 2.3 0.60e 0.569 0.005 1.48 0.02 5.3 0.60
L. johnsonii ATCC 33200 ND ND ND ND ND ND
aND, not determined.
bSignificant difference in the asymptotic OD value of B. longum UCD401 compared to L. plantarum and to the positive control, glucose (P  0.05).
cSignificant difference in the asymptotic OD value of L. plantarum compared to B. longum UCD401 and to the positive control, glucose (P  0.05).
dSignificant difference in the inflection point (tc) of B. longum UCD401 compared to L. plantarum and to the positive control (P  0.05).
eSignificant difference in the inflection point (tc) of L. plantarum compared to B. longum UCD401 (P  0.05).
fSignificant difference in the growth rate (k) of L. plantarum on xyloglucans compared to that of other strains on xyloglucans and glucose (P  0.05).
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molecular-weight oligosaccharides across its envelope. This suggests that a dynamic
equilibrium has been achieved between the import of lower-DP molecules and the
extracellular hydrolysis of higher-DP molecules. This is consistent with higher-DP
oligosaccharide accumulation in the growth medium. A similar glycan distribution was
observed in L. plantarum qualitatively, along with corresponding degradation pheno-
types (Fig. S3). It is important to note that glycoprofiling was performed with bacteria
grown in microcentrifuge tubes.
Bifidobacteria metabolize xyloglucans via the bifid shunt. Metabolite end prod-
ucts secreted while utilizing xyloglucans were quantified by high-performance liquid
chromatography (HPLC) of cell-free supernatants. The absolute concentrations of ace-
tate, lactate, and formate secreted by B. longum subsp. longum UCD401 in the early
stationary phase of xyloglucan or glucose utilization are depicted in Fig. 3. B. longum
subsp. longum UCD401 secretes significantly lower lactate and acetate concentrations
while utilizing xyloglucans (4.08  0.16 and 8.78  0.10 mM, respectively) than when
subsisting on glucose (37.60  9.41 and 54.11  13.40 mM, respectively). This is
expected and consistent with the lower biomass achieved (P  0.05). In addition, less
metabolic investment is required to catabolize glucose in the bifid shunt. The absolute
concentrations were normalized with respect to the OD600 reached in microcentrifuge
tubes. UCD401 exhibited higher acetate concentrations in xyloglucan metabolism
(172.54  10.52 mM) than in glucose metabolism (124.56  22.70 mM), whereas the
lactate concentrations were similar (80.31  6.76 and 86.50  15.98 mM). Interestingly,
and despite a lower biomass, B. longum subsp. longum UCD401 secretes high concen-
trations of formate while metabolizing cranberry xyloglucans (10.01  0.86 mM). This
is significantly higher than during glucose utilization (1.62  1.30 mM) (P  0.05),
indicating a shift in metabolism to harvest energy more efficiently from this substrate.
The bifid shunt catabolizes hexose sugars to yield a theoretical acetate:lactate ratio
of 1.5. As expected, UCD401 achieved this while utilizing glucose (1.44  0.01);
however, xyloglucan fermentation shifted the ratio significantly toward acetate at the
expense of lactate (2.15  0.08) (P  0.05) (Fig. 3d). When normalizing the absolute
concentrations with respect to biomass, more acetate production from xyloglucan
metabolism than from glucose metabolism occurred. This has been observed in a
previous study, as more ATP is produced by flux through acetate-producing pathways
FIG 3 Bacterial fermentative end products of cranberry xyloglucan utilization. Shown are lactate (a), acetate (b), and
formate (c) production; acetate/lactate ratios (d); and formate/lactate ratios (e). Bl, B. longum subsp. longum
UCD401; Lp, Lactobacillus plantarum ATCC BAA-793. Averages of independent biological triplicates are shown, and
bars represent the standard deviation of the mean. Organic acid production is expressed in millimolar absolute
concentrations. Asterisks represent significant differences determined by two-way ANOVA and Sidak’s multiple-
comparison test (P  0.05).
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(31). Accordingly, formate secretion was significantly increased with a formate:lactate
ratio of 2.50  0.28 while fermenting xyloglucans, in contrast to 0.05  0.01 during
glucose metabolism (Fig. 3e).
Organic acids produced while lactobacilli ferment xyloglucans were subsequently
profiled (Fig. 3). In addition to comparative physiology, this approach may inform future
mixed-culture probiotics (i.e., lactobacilli and bifidobacteria), as well as synbiotic strat-
egies that incorporate xyloglucans with one or more probiotic strain. Lactate was
produced at significantly lower concentrations (5.27  0.19 mM, P  0.05) by L.
plantarum ATCC BAA-793 than during glucose consumption. In addition, acetate
secretion was observed with an acetate:lactate ratio of 1:1 when L. plantarum ATCC
BAA-793 utilized cranberry xyloglucans (Fig. 3d). While fermenting glucose, L. planta-
rum exhibited an acetate:lactate ratio of 0.05  0.01 (P  0.05) (Fig. 3d). We expected
L. plantarum, as a heterofermentative species, to secrete acetate. Interestingly, formate
production was detected during xyloglucan consumption, although it was not detected
following glucose fermentation. The secretion of acetate and formate has been previ-
ously observed when inefficient substrate utilization yielded less biomass (32, 33).
Bacterial commensals exhibit differential growth phenotypes while consuming
oligosaccharide extracts containing secondary plant material. In addition to puri-
fied xyloglucans, crude cranberry cell wall extracts were evaluated as a growth sub-
strate. These fractions are more crudely enriched for oligosaccharides and thus more
closely mimic what would be encountered by the microbiota following the ingestion of
cranberries. Moreover, prebiotic formulations would likely use a crude cranberry extract
for functional or processing reasons.
We tested two crude fractions, termed A2, which retains a pink color and is extracted
from whole cranberries, and A6, which is derived from the primary A2 fraction. Both of
these preparations have been previously reported (22). However, the precise distribu-
tion of glycans and noncarbohydrate molecules in A2 is not fully characterized.
Accordingly, B. longum strains achieved more pronounced growth phenotypes while
consuming A2 and A6. Cellular growth (Fig. 4) and kinetics varied by the particular
strain tested (Table 3). A2 was most vigorously utilized by B. longum subsp. infantis
JCM7007 (OD600 of 0.58  0.34), B. longum subsp. infantis JCM1272 (OD600 of 0.38 
0.10), and B. longum subsp. longum UCD401 (0.37  0.07) (Fig. 4a; Table 3). With the
exception of UCD401, these strains did not grow on purified xyloglucans. Interestingly,
there are two B. longum subsp. infantis strains that utilize A2 as a substrate. This is
significant, as B. longum subsp. infantis is predicted not to utilize xyloglucans; thus,
other components of the A2 fraction were fermented or cofermented. In addition, B.
longum subsp. infantis JCM1272 achieved moderate growth on A2 (OD600 of 0.17 
0.08), whereas growth on purified xyloglucans was not observed.
In contrast, the more purified A6 fraction was utilized only by B. longum subsp.
longum UCD401 and B. longum subsp. infantis JCM 1260, with final OD600s of 0.27 
0.03 and 0.08  0.02, respectively (Fig. 4b). Clearly, the A6 fraction is not as efficiently
utilized as the cruder and likely polyphenol-containing A2 fraction (Table 3; Fig. S7).
UCD401 exhibited a gradual decline in growth efficiency while utilizing the crudest
extract to the most purified form (Fig. S7b) (P  0.05). This mirrors the general trend
that the majority of bifidobacterial strains tested do not metabolize highly purified
xyloglucans. This includes all B. longum subsp. infantis strains (Fig. S7c).
B. longum subsp. longum UCD401 utilizes A6, leading to an increase in the acetate:
lactate ratio (1.90  0.16) and absolute formate production (8.87  2.63 mM) relative
to those achieved with glucose, despite the lower biomass (P  0.05) (Fig. 5). Formate
production by UCD401 is greater than that by B. longum subsp. infantis JCM1260 when
catabolizing A6 (P  0.05). This is consistent with formate secretion while utilizing
highly purified xyloglucans and suggests that UCD401 is specifically consuming this
substrate in the mixed-purity preparation. Interestingly, B. longum subsp. infantis
JCM1260 exhibits an acetate:lactate ratio of 2.44  0.32 and 6.39  0.57 mM formate
secreted (Fig. 5c). Glucose flux through the bifid shunt was metabolized, as expected,
to approximate the theoretical yield of 1.5 (1.82  0.15 and 1.43  0.01) (P  0.05)
Özcan et al. Applied and Environmental Microbiology
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(Fig. 5d). Again, this is consistent with utilization of the carbohydrate constituents of the
A6 fraction.
Expression of arabinose utilization genes while utilizing the A6 cranberry
xyloglucan fraction. The expression of four GH family genes in the UCD401 chromo-
some while metabolizing A6 was evaluated. This includes an -L-arabinofuranosidase
gene (BL_0405), two arabinan endo-1,5--L-arabinosidase genes (BL_0404, BL_0403),
and a -xylosidase gene (BL_0402). We observed that BL_0405, BL_0404, and BL_0402
were significantly upregulated, with a minimum of a 2-fold increase during exponential
TABLE 3 Kinetic analysis of bacterial growth on A2 and A6 fraction xyloglucans calculated with Wolfram Mathematica 10.3
Strain
Xyloglucans from fraction:
A2 A6
k (h1) ODasym tc (h) k (h1) ODasyma tc (h)
B. infantis JCM 1260 0.464 0.280 0.17 0.08 6.4 3.3 1.188 0.79 0.08 0.02a 3.3 1.8
B. infantis JCM 1272 0.427 0.039 0.38 0.10 12.4 0.6 NDc ND ND
B. infantis JCM 7007 0.215 0.137 0.58 0.34 17.6 6.1 ND ND ND
B. infantis ATCC 15697 NAd NA NA ND ND ND
B. longum JCM 11347 ND ND ND ND ND ND
B. longum ATCC 15708 ND ND ND ND ND ND
B. longum UCD401 0.438 0.152 0.37 0.08 11.3 3.0 0.270 0.084 0.27 0.03b 16.3 0.6
L. plantarum ATCC BAA-793 NA NA NA 0.513 0.061 0.25 0.02b 2.9 0.5
L. johnsonii ATCC 33200 NA NA NA 0.944 0.166 0.12 0.01a 1.4 0.3
aSignificant difference in the asymptotic OD values for JCM 1260 and L. johnsonii compared to UCD401 and L. plantarum in A6 fraction treatment (P  0.05).
bSignificant difference in the asymptotic OD values for UCD401 and L. plantarum compared to JCM 1260 and L. johnsonii in A6 fraction treatment (P  0.05).
cND, not determined.
dNA, not available.
FIG 4 Bacterial growth on additional fractions of cranberry xyloglucans. Growth curves represent B.
longum subsp. infantis ATCC 15697, JCM 1260, JCM 1272, and JCM 7007; B. longum subsp. longum JCM
11347, ATCC 15708, and UCD401; Lactobacillus plantarum ATCC BAA-793; and Lactobacillus johnsonii
ATCC 33200 grown on mMRS medium containing 2% (wt/vol) xyloglucan fraction A2 (a) or 2% (wt/vol)
xyloglucan fraction A6 (b). The curves are drawn from the average of at least three independent
experiments, with the exception of strains JCM 1260, JCM 7007, JCM 11347, and JCM 15708 which are
based on duplicates in panel a.
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phase (Fig. 6a, P  0.05). This indicates that the expression of these genes and their
products is modulated during the utilization of the A6 xyloglucan fraction. Interestingly,
BL_0403 expression did not significantly change relative to that of the glucose control
(P  0.05). This indicates that the adjacent BL_0404 gene is responsible for xyloglucan
hydrolysis. Moreover, differential regulation of these paralogs potentially reflects diver-
gent enzymatic functions.
Fermentation of the A6 fraction induces UCD401 to express transport-related pro-
teins that may be involved in xyloglucan transport across the membrane. Upregulated
transport genes, including those for a carbohydrate ABC transporter substrate-binding
protein (BL_0398) and carbohydrate ABC transporter membrane proteins (BL_0397,
BL_0396) exhibit 2-fold induction relative to the control (Fig. 6b, P  0.05). This
suggests recognition and a potential uptake of arabinose and xylose backbone motifs
across the cell envelope.
Modeled bidirectional syntrophic interactions. Conditioned spent medium from
xyloglucan fermentations was used to assess in vitro bidirectional syntrophic interac-
tions in microplate growth. This occurs when fermentation by a primary strain provides
hydrolysis products to be used by a heterologous secondary strain that is incapable of
utilizing the initial substrate. Since L. johnsonii does not grow on xyloglucans on a
microplate, we included this strain as a negative control. Interestingly, B. longum subsp.
infantis ATCC 15697 does not utilize purified xyloglucans as a sole carbon source;
however, conditioned supernatants from L. plantarum and L. johnsonii enabled growth
to final OD600s of 0.066  0.008 and 0.093  0.008 with growth rates of 0.940  0.106
h1 and 0.801 0.077 h1, respectively (Table 4). We interpret this as moderate growth
because of the characteristic sigmoidal response curve produced during fermentation.
In contrast, supernatant harvested from B. longum subsp. longum UCD401 did not
enable B. longum subsp. infantis ATCC 15697 to grow (Fig. 7). This is likely due to the
inability of B. longum subsp. infantis ATCC 15697 to utilize arabinosyl-reducing ends, as
predicted by comparative genomics (15). UCD401 may potentially sequester and
FIG 5 Bifidobacterial fermentative end products of cranberry fraction A6 utilization. (a to c) Lactate (a),
acetate (b), and formate (c) production while B. longum subsp. infantis JCM 1260 and B. longum subsp.
longum UCD401 utilize xyloglucan fraction A6. (d) Acetate:lactate ratio after fermentation. Averages of
independent biological triplicates are shown, and bars represent the standard deviation of the mean.
Asterisks represent significant differences evaluated by two-way ANOVA and Sidak’s multiple-
comparison test (P  0.05).
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metabolize molecules that would otherwise be utilized by other bifidobacterial strains.
Furthermore, it is possible that the lactobacilli secreted other products to enhance B.
longum subsp. infantis growth (e.g., exopolysaccharides) (34).
B. longum subsp. infantis ATCC 15697 utilization of carbohydrates liberated from
lactobacilli and UCD401 primary fermentations were analyzed by liquid chromatogra-
phy (LC)-MS (Fig. S8). Of interest, ATCC 15697 grew on the spent medium from
lactobacillus primary fermentations, albeit with a stronger peak intensity observed by
LC-MS. This may be due to hydrolysis of higher-molecular-weight xyloglucans or the
production of exopolysaccharides, as hypothesized with primary fermentations. In
addition, we determined that ATCC 15697 is incapable of utilizing the spent medium
from UCD401 in a secondary fermentation.
When B. longum subsp. longum UCD401 was grown on the L. plantarum superna-
tant, it achieved a lower final OD600 (0.096 0.005) than when it was grown on purified
FIG 6 Gene expression of B. longum subsp. longum UCD401 while utilizing cranberry fraction A6 as a sole
carbon source. Genes in the arabinose cluster of B. longum subsp. longum UCD401 predicted to
participate in xyloglucan metabolism are depicted on the x axis. Expression of four GH family genes
(those for -L-arabinofuranosidase, C-terminal [BL_0405], arabinan endo-1,5--L-arabinosidase [BL_0404,
BL_0403], -xylosidase [BL_0402]) (a) and those for a carbohydrate ABC transporter substrate-binding
protein (BL_0398) and carbohydrate ABC transporter membrane proteins (BL_0397, BL_0396) (b) is
shown as fold change relative to the control (glucose). Averages of independent biological triplicates are
shown, and bars represent the standard deviation of the mean. Asterisks (* and **) represent significant
differences compared to the control (glucose), evaluated by paired t test (P values of 0.05 and 0.005,
respectively).
TABLE 4 Growth kinetics of strains during syntrophic interaction
Strain
Supernatant from:
B. longum UCD401 L. plantarum ATCC BAA-793 L. johnsonii ATCC 33200
k (h1) ODasym tc (h) k (h1) ODasym tc (h) k (h1) ODasym tc (h)
B. infantis ATCC 15697 NDe ND ND 0.940 0.106a 0.066 0.008 10.3 0.6 0.801 0.077 0.093 0.008 10.3 0.6
B. longum UCD401 NAf NA NA 0.632 0.120b 0.096 0.005d 12.8 0.6 0.468 0.070d 0.162 0.007c 11.0 0.0
L. plantarum ATCC BAA-793 0.890 0.158d 0.115 0.009d 2.1 0.9 NA NA NA NA NA NA
aSignificant difference between the growth rates of B. infantis ATCC 15697 in different conditioned media determined by paired t test (P  0.05).
bSignificant difference between the growth rates of B. longum UCD401 in different conditioned media determined by paired t test (P  0.05).
cSignificant difference between the asymptotic OD values of B. longum UCD401 in different conditioned media determined by paired t test (P  0.05).
dSignificant difference in the growth kinetics of each strain in different conditioned media and its growth kinetics in xyloglucans alone (shown in Table 2) determined
by paired t test (P  0.05).
eND, not determined.
fNA, not available.
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xyloglucans in a primary fermentation (P  0.05), although the growth rates are similar
regardless of whether UCD401 is conducting a primary or a secondary fermentation
(Table 4). Conversely, the growth rate of L. plantarum on conditioned medium from B.
longum subsp. longum UCD401 was significantly higher whereas its biomass production
(final OD600 of 0.115  0.009) was significantly lower than that of purified xyloglucans
(final OD600 of 0.29  0.03) (P  0.05) (Table 4). This may indicate the production of
inhibitory compounds or a preference for intact oligosaccharides.
DISCUSSION
It has been established that genotypic and phenotypic variations contribute to
bifidobacterial preferences for carbon sources (12). For the former, the B. longum subsp.
infantis genome has evolved to enable milk oligosaccharide utilization at the expense
of plant carbohydrates. Bifidobacteria deploy transporters to capture intact oligosac-
charides or their derivatives from the extracellular milieu (13, 35). Thus, the inability of
B. longum subsp. infantis strains to utilize xyloglucans may be due to the absence of
specific transporters. This is consistent with B. longum subsp. infantis ATCC 15697
utilization of lactobacillus hydrolysis products. These lactobacilli perform extracellular
digestion to provide ATCC 15967 with fermentable substrates. In contrast, UCD401
internalizes intact oligosaccharides to withhold potential growth substrates from ATCC
15697.
It is likely that B. longum subsp. longum UCD401 utilizes xyloglucans from the
terminal arabinose positioned at the reducing end. This is consistent with the expres-
sion of arabinose utilization genes (Fig. S9). This arabinose utilization cluster is con-
served in B. longum subsp. longum strains with an araC transcriptional family operon
upstream of -L-arabinofuranosidase and -xylosidase genes adjacent to an ABC
transporter cassette. Importantly, B. longum subsp. longum ATCC 15707 does not grow
on xylose but metabolizes arabinose as a sole carbohydrate source (36). Accordingly, B.
longum subsp. longum UCD401 utilizes arabinose more efficiently than do the other B.
longum subsp. longum strains tested (Fig. S10). It is noteworthy that this B. longum
strain was isolated from an infant stool sample and the stronger utilization phenotype
may reflect recent isolation and limited passages.
Bifidobacterial xyloglucan utilization requires the transport of arabinose following
extracellular hydrolysis of higher-DP oligosaccharides. -D-Glucopyranosyl and -D-
xylopyranosyl residues are not metabolized extracellularly. This likely causes the accu-
mulation of lower-DP xyloglucans. Arabinose metabolism has been linked to genes
encoding extracellularly secreted -arabinofuranosidases, which are located within the
UCD401 genome (Fig. S4) (37). As we predicted, B. longum subsp. longum UCD401
utilizes xyloglucan within the crude A6 fraction likely by using an extracellular arabi-
nofuranosidase (BL_0405). Arabinose liberated from xyloglucans was completely se-
questered, as it was not detected in spent medium. It has been posited that bifido-
FIG 7 Bacterial syntrophic interactions modeled with cranberry xyloglucans. Growth curves of B. longum
subsp. infantis ATCC 15697 on mMRS medium containing xyloglucans (green) and supernatants from B.
longum subsp. longum UCD401 (orange), L. plantarum ATCC BAA-793 (blue), and L. johnsonii ATCC 33200
(yellow) after xyloglucan fermentation. The curves are drawn from an average of three independent
experiments.
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bacterial strains cannot use xylose backbones longer than xylotetraose (DP of 4) (37).
The B. longum subsp. longum arabinose cluster encodes predicted intracellular xylosi-
dases, which supports the hypothesis that transport is essential for the catabolism of
higher (DP of 4) xylooligosaccharides (Fig. S4). The upregulation of solute-binding
transport proteins (BL_0398) and permeases (BL_0397 and BL_0396) suggests that
uptake of arabinose and lower-DP xyloglucans, including xylose and glycosyl residues,
occurs after the release of arabinose moieties.
In bifidobacterial carbohydrate metabolism, pyruvate is converted to lactate via
lactate dehydrogenase, which does not produce additional ATP but recycles NAD (38).
Pyruvate formate-lyase (pfl; EC 2.3.1.54) catalyzes formate and acetyl-coenzyme A
(acetyl-CoA) production from pyruvate. Acetyl-CoA is subsequently metabolized to
acetate or ethanol and secreted (38). This results in an increased acetate/lactate ratio
and correspondingly higher ATP production (31, 38). We predicted increased acetate
secretion during UCD401 xyloglucan fermentation, although the lower biomass on this
substrate hinders comparisons of absolute concentrations. However, formate and
ethanol secretion was previously determined to impact the acetate/lactate ratio in
bifidobacteria (38). Thus, the shift toward formate production coincides with an in-
creased need for ATP while metabolizing xyloglucans. Bifidobacterial secretion of
formate while utilizing certain oligosaccharides has been previously observed (39–41).
Under certain conditions, bifidobacterial oligosaccharide metabolism is initially char-
acterized by high levels of lactate production, with a shift toward formate production
occurring later in the fermentation (40, 42, 43). This suggests that formate production
benefits the cell by generating additional ATP when oligosaccharides are catabolized
slowly. In general, bifidobacteria secrete secondary products such as formate, succinate,
and ethanol when achieving lower biomass concentrations (OD600 of 0.5) and when
the carbohydrate consumption rate is diminished (31, 39, 40, 42). Our results are
consistent in that formate production increases while xyloglucans are utilized slowly,
ostensibly to bolster ATP production under these conditions.
Crude oligosaccharide extracts were tested, as they is of interest for the preparation
of cranberry xyloglucans for prebiotic applications. The cranberry cell wall does not
contain appreciable quantities of monosaccharides (44) and is not expected to influ-
ence growth (22). As the A2 fraction retains a pink color, there are likely small quantities
of phenolic compounds that may contribute to the observed growth differential
between the A2 fraction and the highly purified xyloglucans. Furthermore, the most
abundant oligosaccharides within the A6 fraction are identical to the xyloglucans
purified in this study (22). However, XSGGG-Ac and XSGGG-Ac2 structures (i.e., acety-
lated xyloglucan oligosaccharides) have been identified in the A6 fractions and did not
remain in the highly purified xyloglucans. Thus, these oligosaccharides may be respon-
sible for promoting L. johnsonii and B. longum subsp. infantis JCM1260 growth. B.
longum typically consumes short-chain oligosaccharides, likely subsequent to intracel-
lular transport (13, 45). Thus, it is possible that differential phenotypes are due to
variation in the xyloglucan DP.
Lactobacilli are natural inhabitants of the human gastrointestinal tract and may be
used as probiotics and in concert with prebiotics in synbiotic applications (26, 46).
Lactobacillus strains may utilize carbohydrates as well as bifidobacteria (47). It is likely
that L. plantarum uses the phosphoketolase pathway while consuming xyloglucans to
secrete formate and acetate, with lactate being reduced (48, 49). This was previously
observed in L. plantarum VTT E-79098 fermentation of arabino-xylooligosaccharide (33).
Our experiments suggest that syntrophic interactions following xyloglucan degra-
dation may occur between other members of the gut consortium. The interactions
among lactobacilli, bifidobacteria, and oligosaccharides are of interest in the engineer-
ing of synbiotic interventions. Moreover, lactobacillus-mediated cleavage of xyloglu-
cans within the small intestine would impact substrates available to bifidobacterial
commensals of the lower gastrointestinal tract. Syntrophic interactions during bifido-
bacterial in vitro cofermentations that include members of the genus Bifidobacterium on
various carbohydrate sources have been previously described (12, 45, 50). Cooperative
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or cross-feeding between strains that colonize the gastrointestinal tract may contribute
to the competitive exclusion of sensitive taxa and maintain diversity through specialist
adaptation to colonize unique niches (51). Such syntrophic interactions under in vivo
conditions might prompt a shift in the gut microbiome toward the metabolism of
plant-derived carbohydrates with a metabolome characteristic of saccharolytic activi-
ties (52). We did not detect monosaccharides in spent medium by HPLC, leading to the
hypothesis that liberated monosaccharides would be sequestered, thus rendering them
undetectable. Furthermore, it is possible that the transfer of conditioned medium from
the primary fermentation introduced end products into the secondary fermentation
although at very low concentrations with minimal impact on growth.
Conclusions. Among the bifidobacterial strains tested, B. longum subsp. longum
UCD401 utilizes cranberry xyloglucans as a sole energy and carbon source. This is
potentially significant, as it was recently isolated from an infant and subjected to
limited passages. This may be due to conserved phenotypic function, as genomic or
regulatory features likely remained intact in the limited generations since its isolation
(53). Furthermore, it hints at the potential for strain variation within infants and adults
in the capacity to utilize cranberry xyloglucans. B. longum subsp. longum colonizes both
infants and postweaning individuals. The phenotypic versatility underlying the broad
host range necessary to subsist on a substrate encountered in the adult diet suggests
a postweaning strategy. It is notable that xyloglucan catabolism prompts a shift in the
central fermentative pathway to obtain more ATP. The significance of the altered
metabolic profile for microbiome function or host health remains an outstanding
question.
MATERIALS AND METHODS
Isolation of xyloglucans from the cranberry cell wall. Cranberry hulls were degraded with
pectinase (Klerzyme 150; DSM Food Specialties, South Bend, IN, USA) and fractionated as previously
described (24), with modifications. Briefly, 2 g of cranberry pectinase-treated powder was dissolved in 20
ml of distilled water and loaded onto a RediSep GOLD C18 reverse-phase column (Teledyne ISCO, Inc.,
Lincoln, NE, USA) connected to a CombiFlash Rf purification system (Teledyne ISCO, Inc.) The column was
eluted sequentially with 500 ml of deionized water, 500 ml of 15% methanol-water, and 500 ml of
methanol. Fractions from all of the gradients were individually pooled and lyophilized to obtain three
major fractions, Cranf1W (761 mg, 38.1%) eluted with 100% deionized water, Cranf1b (476 mg, 23.8%)
eluted with 15% methanol-water, and Cranf1M (562 mg, 28.1%) eluted with 100% methanol. A 100-mg
sample of Cranf1b was then dissolved in 2 ml of distilled water and further purified with a size exclusion
column HiPrep Sephacryl S-100 HR 16/60 (GE Healthcare Life Sciences, Pittsburgh, PA, USA). The column
was isocratically eluted with deionized water at 0.5 ml/min. Eluates were collected from every 5-ml
volume and evaluated for their total carbohydrate content by phenol sulfuric acid assay (54). The total
carbohydrate content was assessed with a 96-well microtiter plate as previously reported (54). Briefly, in
each well of a 96-well microtiter plate, 30 l of each fraction was mixed with 100 l of concentrated
sulfuric acid and 20 l of 5% phenol solution. The microtiter plate was than incubated at 90°C for 5 min,
and the absorbance at 490 nm was recorded with a SpectraMax M2 microplate reader (Molecular
Devices, Sunnyvale, CA, USA).
Xyloglucan structural analysis. Oligosaccharide fractions were pooled and freeze-dried to obtain
59.5 mg of cranberry xyloglucans, which was then chemically verified by a combination of MALDI-TOF
MS and 1H NMR spectroscopy. Briefly, 1 l of xyloglucan (1 mg/ml in H2O) was mixed with 1 l of
2,3-dihydrobenzoic acid matrix solution. A 2-l volume of this mixture was analyzed by MALDI-TOF MS
(Axima Performance, Shimadzu, Kyoto, Japan) in positive reflectron mode. Five hundred profiles were
collected for each experiment. Furthermore, the cranberry xyloglucans were dissolved in D2O (99.96%;
Cambridge Isotope Laboratories Inc., Tewksbury, MA, USA). The 1H NMR spectrum was obtained on a
500-MHz NMR spectrometer (Varian VNMR; Agilent Technologies, Santa Clara, CA, USA) at 25°C.
Bacterial strains and propagation. The bacterial strains used in this study are summarized in Table
1. Bifidobacterial strains were propagated in bifidobacterial selective medium or De Man-Rogosa-Sharpe
(MRS; Oxoid, Hampshire, England) medium supplemented with 0.05% (wt/vol) L-cysteine (Sigma-Aldrich,
St. Louis, MO) (55) at 37°C under anaerobic conditions (Coy Laboratory Products, Grass Lake, MI).
Lactobacillus cultures were propagated in MRS medium supplemented with 0.05% (wt/vol) L-cysteine as
a reducing agent at 37°C under anaerobic conditions. Bacterial strains were routinely verified with the
bifidobacterium-specific phosphoketolase assay (56) and through microscopy. The strains used in this
study have been previously confirmed by multilocus sequence typing and urease assay to distinguish B.
infantis and B. longum (urease and urease) (16). In addition, a PCR-based B. longum/B. infantis ratio
analysis was performed to differentiate B. longum subspecies as previously described (57).
Microplate growth assay. To evaluate growth phenotypes in a 96-well format, overnight cultures
were centrifuged and washed with phosphate buffer solution that was inoculated (1% [vol/vol]) into
modified MRS (mMRS) medium (without acetate and carbohydrate substrate). The sole carbon source
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was defined as purified xyloglucans at a final concentration of 2% (wt/vol). The growth assay was
conducted anaerobically at 37°C for 72 h by assessing OD600 with an automated PowerWave HT
microplate spectrophotometer (BioTek Instruments, Inc., Winooski, VT). Each strain was evaluated in
biological triplicate with three technical replicates. Negative and positive controls consisted of inoculated
medium in the absence of substrate and the presence of glucose (2% [wt/vol]), respectively. Bacterial
growth kinetics were calculated with Wolfram Mathematica 10.3 Student Edition as described by Dai et
al. (58) in accordance with the equation ΔOD(t) ΔODasym{[1/1 exp(ktc t)] [1/1 exp(ktc)]}, where
ΔODasym is the growth level at stationary phase with k representing the growth rate and tc is the
inflection point indicating the time required to reach the highest growth rate.
Modeled syntrophic interactions. To determine if degradative or secreted metabolites are utilized
by a heterologous strain, supernatants from microplate-grown bacteria were analyzed. Accordingly, 800
l of the conditioned supernatant was dissolved in 1,200 l of mMRS medium. Bacterial strains were
washed once with phosphate-buffered saline to remove the residual carbohydrates from the initial
propagation, inoculated at 1% (vol/vol), and evaluated for growth in a 96-well format as already
described. Bacterial growth kinetics were calculated, and the supernatant obtained after the secondary
growth was analyzed by HPLC.
Xyloglucan profiling following bacterial fermentation. Following in vitro fermentation, filtered
bacterial culture supernatants were derivatized with 2-aminobenzamide (2-AB) for oligosaccharide
purification. Briefly, 50 l of cell-free supernatant was diluted with 2 ml of deionized water and loaded
onto a porous graphitized carbon cartridge (1 g; Thermo Scientific, Waltham, MA, USA). The cartridge was
prewashed with 5 ml of 50% (vol/vol) acetonitrile-H2O and equilibrated with 3 5 ml of deionized water.
First, the cartridges were eluted with 5 ml of deionized water three times with oligosaccharide fractions
eluted with 30% (vol/vol) acetonitrile-H2O with 0.1% trifluoroacetic acid (TFA) three times. The resulting
fractions were spiked with 0.036 mg of glucose as an internal standard and freeze-dried. 2-AB at 7 mg/ml
and 2-picoline borane at 3.2 mg/ml were prepared in 10% (vol/vol) acetic acid-H2O, and 200 l was
added to each mixture. The solutions were held at 40°C for 4 h, centrifuged, and dried in vacuo. The
derivatized oligosaccharide mixtures were redissolved in 400 l of deionized water for fluorescence
detection (FL)-HPLC and LC-MS analyses.
FL-HPLC and LC-MS analyses. The 2-AB-labeled xyloglucans were analyzed by FL-HPLC and LC-MS.
FL-HPLC analysis was performed with a Hitachi Elite LaChrom HPLC system (Hitachi, Tokyo, Japan)
connected to a fluorescence detector (L-2485; Hitachi). The samples were analyzed on a Kinetex
reverse-phase C18 column (150 by 3 mm, 2.6 m; Phenomenex, Torrance, CA, USA) at 40°C. The column
was first eluted with isocratic 10% (vol/vol) methanol in H2O (with 0.1% TFA) for 10 min at 0.2 ml/min,
followed by a linear gradient of 10 to 20% methanol in H2O for 90 min and then a linear gradient of 20
to 100% methanol in H2O for 15 min, and kept at 100% methanol for 30 min. Elution was monitored with
a fluorescence detector with an excitation wavelength of 330 nm and an emission wavelength at 420 nm.
LC-MS analysis was performed with a Shimadzu Prominence UFLC system (Shimadzu, Kyoto, Japan)
coupled to an AB Sciex QTrap 4500 mass spectrometer (AB Sciex, Framingham, MA, USA) with an
electrospray ionization source. The LC-MS analysis was performed with the same column and the same
HPLC program as aforementioned for FL-HPLC. The mass spectrometer was operated in positive mode,
and ions at m/z 200 to 2,000 were scanned. Quantification of extracted ions was normalized by
2-AB-derivatized glucose.
Characterization of bacterial organic acid production. End products of bacterial fermentation
were quantitated by HPLC. Bacterial strains were initially propagated as described above. Cell-free
supernatants from microcentrifuge tubes were obtained at early stationary phase, filtered through a
0.22-m filter following centrifugation, and stored at 80°C until analysis. Organic acids were quantified
with an Agilent 1260 Infinity HPLC system (Agilent Technologies, Santa Clara, CA) equipped with a Wyatt
Optilab T-rEX refractive-index detector (Wyatt Technology Corp., Santa Barbara, CA). Separation was
carried out with an Aminex HPX-87H column (7.8 mm [inside diameter] by 300 mm; Bio-Rad Laboratories,
Hercules, CA) at 50°C in a mobile phase of 5 mM H2SO4 at a flow rate of 0.6 ml/min with a 50-l injection
volume. Organic acids (i.e., acetic acid, lactic acid, and formic acid) were acquired from Sigma-Aldrich Co.
(St. Louis, MO). Metabolite concentrations were calculated from standard curves derived from external
standards for six different concentrations (0.05, 0.1, 0.5, 1, 5, and 10 mg/ml) and converted to millimolar
values. Metabolite profiling was carried out in triplicate, and each measurement was performed in
duplicate.
Gene expression by qRT-PCR. Relative gene expression was performed by quantitative real-time
PCR (qRT-PCR). Four-milliliter samples were collected at mid-exponential phase, pelleted at 12,000  g
for 2 min, and stored in 1 ml of Ambion RNAlater (Life Technologies, Carlsbad, CA). Total RNA was
extracted with the Ambion RNAqueous minikit (Life Technologies, Carlsbad, CA) in accordance with the
manufacturer’s instructions. The cells were placed in lysis buffer, transferred to MP Bio Matrix E tubes, and
subjected to bead beating with a FastPrep 24 instrument (MP Biomedicals, Santa Ana, CA) (2  5.5 m/s
for 30 s). Total RNA was eluted in 50 l of EB solution and immediately subjected to DNase treatment
with the Ambion Turbo DNA-free kit (Life Technologies, Carlsbad, CA) with 1 l of DNase I for 0.5 h. Total
RNA was converted to cDNA with the High Capacity cDNA reverse transcription kit (Applied Biosystems,
Carlsbad, CA) in accordance with the manufacturer’s instructions. cDNA concentrations were measured
with a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific Inc., Agawam, MA). qRT-PCR analysis
was performed with a 7500 Fast real-time PCR system (Applied Biosystems, Singapore) with PowerUP
SYBR green master mix (Applied Biosystems, Foster City, CA) and the parameters suggested by the
manufacturer. Primers were designed with Primer3 (Table 5; http://frodo.wi.mit.edu). The Blon_0393
gene was used as an endogenous control as previously validated (59). Gene expression levels during
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growth on glucose (2%, wt/vol) were used as a reference. Results were expressed as fold changes relative
to the control. Bacterial growth was performed in triplicate with triplicate measurements by qRT-PCR.
Statistical analysis. Bacterial growth kinetics were subjected to two-way analysis of variance
(ANOVA) and Tukey’s honestly significant difference test for multiple comparisons of strains within a
treatment compared with the positive control. Metabolite concentrations were subjected to two-way
ANOVA, and Sidak’s correction was used to account for multiple comparisons. Significant differences in
modeled syntrophic interactions were determined by paired t test for bacterial growth kinetics. The fold
change in gene expression compared to the control was analyzed by paired t test.
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